Who is sponsoring NCT05385107?

NCT05385107 is sponsored by Karolinska University Hospital.

What drugs are being tested in NCT05385107?

Interventions in NCT05385107: Serum procalcitonin concentration.

What condition does NCT05385107 study?

NCT05385107 studies The Value of Procalcitonin in Patients With Suspected Candidemia.

Is NCT05385107 still recruiting?

NCT05385107 is currently completed. Last updated 23 May 2022.

Last reviewed 2022-05-23 · How we verify

NCT05385107

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Value of PCT When Diagnosing Candidemia

Completed Last updated 23 May 2022

What this trial tests

trial testing Serum procalcitonin concentration in The Value of Procalcitonin in Patients With Suspected Candidemia in 49 participants. Completed in 12 December 2021.

Timeline

1 April 2010

Primary endpoint
31 December 2015

12 December 2021

Quick facts

Lead sponsor	Karolinska University Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	49
Start date	1 April 2010
Primary completion	31 December 2015
Estimated completion	12 December 2021
Sites	1 location across Sweden

Drugs / interventions tested

Serum procalcitonin concentration

Conditions studied

The Value of Procalcitonin in Patients With Suspected Candidemia — all drugs for The Value of Procalcitonin in Patients With Suspected Candidemia →

Sponsor

Karolinska University Hospital

Who can join

18 and older, any sex, with The Value of Procalcitonin in Patients With Suspected Candidemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a retrospective analysis to identify and compare the shift in inflammatory biomarkers in ICU patients immediately before and after the first identification of candidemia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Karolinska University Hospital trials

Trials by the same sponsor.

NCT07424690 — Catheter Ablation vs Conservative Care in Elderly Patients With Atrial Fibrillation · NA · not yet recruiting
NCT06639191 — [177Lu]Lu-AKIR001 First-in-human Study · EARLY_PHASE1 · recruiting
NCT03629977 — Timing of Renal Replacement Therapy in the Critically Ill Patients · recruiting
NCT06983197 — Iatrogenic Deficiencies in ICU Patients With Prolonged Continuous Renal Replacement Therapy · not yet recruiting
NCT06835816 — Amino Acid Supplementation in Continuous Renal Replacement Therapy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05385107 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska University Hospital
Last refreshed: 23 May 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05385107.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing